The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 17,368 2,359,767 SH   SOLE   2,359,767 0 0
Aldeyra Therapeutics Inc COM 01438T106 4,371 484,096 SH   SOLE   484,096 0 0
Altria Group Inc COM 02209S103 5,169 90,000 SH   SOLE   90,000 0 0
Anavex Life Sciences Corp COM NEW 032797300 2,209 724,205 SH   SOLE   724,205 0 0
Biohaven Pharmactl Hldg Co L COM G11196105 38,593 749,815 SH   SOLE   749,815 0 0
Blackstone Group LP COM UNIT LTD 09253U108 5,350 153,000 SH   SOLE   153,000 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 34,652 4,985,870 SH   SOLE   4,985,870 0 0
DowDupont Inc COM 26078J100 4,798 90,000 SH   SOLE   90,000 0 0
Eiger Biopharmaceuticals Inc COM 28249U105 1,052 75,238 SH   SOLE   75,238 0 0
Electrocore Inc COM 28531P103 2,778 396,825 SH   SOLE   396,825 0 0
Entera Bio Ltd SHS M40527109 2,057 475,540 SH   SOLE   475,540 0 0
Galmed Pharmaceuticals Ltd SHS M47238106 1,684 206,099 SH   SOLE   206,099 0 0
Krystal Biotech Inc COM 501147102 6,909 209,986 SH   SOLE   209,986 0 0
Kraneshares TR BOSERA MSCI CH 500767405 3,061 96,000 SH   SOLE   96,000 0 0
Lipocine Inc New COM 53630X104 116 50,000 SH   SOLE   50,000 0 0
Molecular Templates COM 608550109 662 113,905 SH   SOLE   113,905 0 0
Soligenix Inc. COM 834223307 767 837,800 SH   SOLE   837,800 0 0